The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression

2013 ◽  
Vol 51 (5) ◽  
pp. 568-575 ◽  
Author(s):  
C. L. Hudson ◽  
A. E. Zemlin ◽  
H. Ipp
Keyword(s):  
Cardiovascular Risk ◽  
Disease Progression ◽  
Immune Activation ◽  
Asymmetric Dimethylarginine ◽  
Risk Marker ◽  
Hiv 1 ◽  
Cardiovascular Risk Marker

scholarly journals MP392IMPACT OF HYPERPHOSPHATEMIA CORRECTIVE THERAPY ON CARDIOVASCULAR RISK MARKER - FGF-23 IN CHRONIC KIDNEY DISEASE PATIENTS

2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i469-i470
Author(s):  
Yuriy Milovanov ◽  
Anna Dudareva ◽  
Ludmila Milovanova ◽  
Lidia Kozlovskaya ◽  
Nikolay Mukhin ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Cardiovascular Risk ◽  
Kidney Disease ◽  
Risk Marker ◽  
Fgf 23 ◽  
Cardiovascular Risk Marker

scholarly journals MP263IMPACT OF TRADITIONAL ANTIHYPERTENSIVE THERAPY ON CARDIOVASCULAR RISK MARKER - KLOTHO IN CHRONIC KIDNEY DISEASE PATIENTS

2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i427-i428
Author(s):  
Svetlana Milovanova ◽  
Nikolay Mukhin ◽  
Ludmila Milovanova ◽  
Lidia Kozlovskaya ◽  
Victor Fomin
Keyword(s):  
Chronic Kidney Disease ◽  
Cardiovascular Risk ◽  
Kidney Disease ◽  
Antihypertensive Therapy ◽  
Risk Marker ◽  
Cardiovascular Risk Marker

scholarly journals MP279IMPACT OF VITAMIN D RECEPTOR ACTIVATORS ON CARDIOVASCULAR RISK MARKER - KLOTHO IN CHRONIC KIDNEY DISEASE PATIENTS

2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i432-i432
Author(s):  
Lidia Kozlovskaya ◽  
Igor Dobrosmislov ◽  
Ludmila Milovanova
Keyword(s):  
Chronic Kidney Disease ◽  
Vitamin D ◽  
Cardiovascular Risk ◽  
Kidney Disease ◽  
Vitamin D Receptor ◽  
Risk Marker ◽  
Cardiovascular Risk Marker

Is Pentraxin 3 a New Cardiovascular Risk Marker in Polycystic Ovary Syndrome?

2014 ◽  
Vol 78 (3) ◽  
pp. 173-178 ◽  
Author(s):  
Umut Sari ◽  
Ikbal Kaygusuz ◽  
Hasan Kafali
Keyword(s):  
Cardiovascular Risk ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Risk Marker ◽  
Pentraxin 3 ◽  
Ovary Syndrome ◽  
Cardiovascular Risk Marker

scholarly journals Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk

PLoS ONE ◽  
2008 ◽  
Vol 3 (4) ◽  
pp. e2021 ◽  
Author(s):  
Pablo Tebas ◽  
William Keith Henry ◽  
Roy Matining ◽  
Deborah Weng-Cherng ◽  
John Schmitz ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
Immune Activation ◽  
Treatment Interruption ◽  
Hiv 1
Sign in / Sign up

Export Citation Format

Share Document